Calumet, Inc. (CLMT) Q3 2025 Earnings Call Transcript

Calumet, Inc. reported a robust Q3 2025, achieving $92.5 million in adjusted EBITDA, fueled by $24 million in operating cost reductions and record production in its Specialty Products & Solutions segment, which maintained strong margins. The company significantly reduced restricted group debt by over $40 million and its RIN obligation by $320 million. Strategically, the Montana Renewables (MRL) MaxSAF expansion remains on schedule for H1 2026, with 75% of its 120-150 million annual gallon SAF capacity already placed through contracts, and the first $25 million in PTCs successfully monetized. Despite current renewable diesel margin headwinds, Calumet anticipates a strong 2026 recovery driven by expected RVO clarity and sustained SAF premiums, while reaffirming deleveraging as a core priority.

Analysis

Calumet Inc. (CLMT) reported a robust Q3 2025, achieving $92.5 million in adjusted EBITDA, its strongest quarter in several years, driven by significant operational efficiencies. The company realized $24 million in operating cost reductions for the quarter and $60 million year-to-date, alongside a $3.37 per barrel reduction in unit operating costs. Balance sheet strength improved with over $40 million in restricted group debt reduction and a $320 million reduction in RIN obligations.

The Specialty Products & Solutions segment demonstrated exceptional resilience, posting a record production quarter with sales volumes exceeding 20,000 barrels per day at strong margins above $60 per barrel, contributing $80.2 million in adjusted EBITDA. Strategically, the Montana Renewables (MRL) MaxSAF expansion is on schedule for H1 2026, with 75% of its 120-150 million annual gallon SAF capacity already secured through contracts. Calumet also successfully monetized its first $25 million in Production Tax Credits (PTCs) in Q3, with another $15 million in October.

Despite industry-wide weakness in renewable diesel margins during Q3, which has since normalized, MRL's adjusted EBITDA with tax attributes increased to $17.1 million. The company anticipates a strong recovery in 2026, driven by expected clarity on the Renewable Volume Obligation (RVO) and sustained SAF premiums, which have seen European prices rise 60% in six months. Deleveraging remains a core strategic priority, targeting an additional $600-$800 million debt reduction, contingent on MaxSAF success and RVO finalization.

Key Decisions for Investors

• Monitor the progress of the MaxSAF expansion and the finalization of the RVO, as these are critical catalysts for Montana Renewables' profitability and overall company deleveraging.
• Evaluate Calumet's continued ability to reduce operating costs and maintain strong margins in its Specialty Products segment, which provides a stable earnings base amidst renewable energy market volatility.
• Assess the company's deleveraging trajectory, particularly the planned $600-$800 million debt reduction, and any strategic activities or MRL monetization efforts that contribute to this goal.